These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Ciappi F, Bria P, Caltagirone C, Bossù P. Am J Geriatr Psychiatry; 2007 Oct 30; 15(10):879-87. PubMed ID: 17911365 [Abstract] [Full Text] [Related]
6. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients. Contreras J, Hernández S, Quezada P, Dassori A, Walss-Bass C, Escamilla M, Raventos H. J Neurogenet; 2010 Jul 30; 24(2):83-9. PubMed ID: 20397838 [Abstract] [Full Text] [Related]
7. Tract-specific analysis of white matter integrity disruption in schizophrenia. Kunimatsu N, Aoki S, Kunimatsu A, Abe O, Yamada H, Masutani Y, Kasai K, Yamasue H, Ohtomo K. Psychiatry Res; 2012 Feb 28; 201(2):136-43. PubMed ID: 22398298 [Abstract] [Full Text] [Related]
8. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Zinkstok J, Schmitz N, van Amelsvoort T, Moeton M, Baas F, Linszen D. Genes Brain Behav; 2008 Feb 28; 7(1):61-9. PubMed ID: 17504246 [Abstract] [Full Text] [Related]
9. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey. Ozbey U, Tug E, Namli M. World J Biol Psychiatry; 2009 Feb 28; 10(4 Pt 2):461-8. PubMed ID: 19153889 [Abstract] [Full Text] [Related]
10. Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. Shin YW, Kwon JS, Ha TH, Park HJ, Kim DJ, Hong SB, Moon WJ, Lee JM, Kim IY, Kim SI, Chung EC. Neuroimage; 2006 May 01; 30(4):1285-91. PubMed ID: 16406258 [Abstract] [Full Text] [Related]
11. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment. Plesnicar BK, Zalar B, Breskvar K, Dolzan V. J Psychopharmacol; 2006 Nov 01; 20(6):829-33. PubMed ID: 16478753 [Abstract] [Full Text] [Related]
12. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC, Bottiglieri T, Wong DH, Halsted CH, Goff DC. Biol Psychiatry; 2008 Jan 01; 63(1):42-8. PubMed ID: 17543893 [Abstract] [Full Text] [Related]
13. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Montag C, Weber B, Fliessbach K, Elger C, Reuter M. Psychol Med; 2009 Nov 01; 39(11):1831-9. PubMed ID: 19335934 [Abstract] [Full Text] [Related]
14. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia. Kang SG, Lee HJ, Choi JE, An H, Rhee M, Kim L. Hum Psychopharmacol; 2009 Jan 01; 24(1):55-60. PubMed ID: 19051221 [Abstract] [Full Text] [Related]
16. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Harada S, Tachikawa H, Kawanishi Y. Biochem Biophys Res Commun; 2001 Feb 23; 281(2):267-71. PubMed ID: 11181039 [Abstract] [Full Text] [Related]
17. Glutathione S-transferase A1 polymorphism as a risk factor for smoking-related type 2 diabetes among Japanese. Oniki K, Umemoto Y, Nagata R, Hori M, Mihara S, Marubayashi T, Nakagawa K. Toxicol Lett; 2008 May 30; 178(3):143-5. PubMed ID: 18430527 [Abstract] [Full Text] [Related]